vs
biote Corp.(BTMD)与IM Cannabis Corp.(IMCC)财务数据对比。点击上方公司名可切换其他公司
biote Corp.的季度营收约是IM Cannabis Corp.的4579.2倍($46.4M vs $10.1K)。biote Corp.净利率更高(4.2% vs -7.8%,领先12.0%)。biote Corp.自由现金流更多($6.5M vs $2.2K)
biote Corp是一家专注于个性化生物同质性激素替代疗法的医疗企业,主要面向美国市场运营,为持牌医疗从业者提供相关培训课程,同时推出配套健康补剂与诊断服务,以提升患者诊疗效果。
IM Cannabis Corp是一家跨国大麻企业,专注于医用及成人娱乐用大麻的种植、生产、分销与零售业务,核心市场覆盖北美、欧盟及以色列,旗下拥有多个大麻品牌,同时销售大麻衍生健康消费品。
BTMD vs IMCC — 直观对比
营收规模更大
BTMD
是对方的4579.2倍
$10.1K
净利率更高
BTMD
高出12.0%
-7.8%
自由现金流更多
BTMD
多$6.5M
$2.2K
损益表 — Q4 2025 vs Q3 2025
| 指标 | ||
|---|---|---|
| 营收 | $46.4M | $10.1K |
| 净利润 | $2.0M | $-790 |
| 毛利率 | — | 22.7% |
| 营业利润率 | 14.7% | -6.9% |
| 净利率 | 4.2% | -7.8% |
| 营收同比 | -6.9% | — |
| 净利润同比 | -47.2% | — |
| 每股收益(稀释后) | $0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BTMD
IMCC
| Q4 25 | $46.4M | — | ||
| Q3 25 | $48.0M | $10.1K | ||
| Q2 25 | $48.9M | $8.8K | ||
| Q1 25 | $49.0M | — | ||
| Q4 24 | $49.8M | $11.8K | ||
| Q3 24 | $51.4M | $9.0K | ||
| Q2 24 | $49.2M | $10.8M | ||
| Q1 24 | $46.8M | $9.1K |
净利润
BTMD
IMCC
| Q4 25 | $2.0M | — | ||
| Q3 25 | $8.2M | $-790 | ||
| Q2 25 | $3.2M | $-4.4K | ||
| Q1 25 | $13.7M | — | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $10.7M | $-1.6K | ||
| Q2 24 | $-7.1M | $-2.5M | ||
| Q1 24 | $-4.2M | — |
毛利率
BTMD
IMCC
| Q4 25 | — | — | ||
| Q3 25 | — | 22.7% | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 21.4% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 23.2% |
营业利润率
BTMD
IMCC
| Q4 25 | 14.7% | — | ||
| Q3 25 | 17.2% | -6.9% | ||
| Q2 25 | 22.0% | -46.7% | ||
| Q1 25 | 19.8% | — | ||
| Q4 24 | 5.6% | -236.7% | ||
| Q3 24 | 23.7% | 18.3% | ||
| Q2 24 | 12.7% | -19.5% | ||
| Q1 24 | 22.3% | 28.9% |
净利率
BTMD
IMCC
| Q4 25 | 4.2% | — | ||
| Q3 25 | 17.1% | -7.8% | ||
| Q2 25 | 6.5% | -49.9% | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 20.8% | -17.3% | ||
| Q2 24 | -14.4% | -23.4% | ||
| Q1 24 | -8.9% | — |
每股收益(稀释后)
BTMD
IMCC
| Q4 25 | $0.05 | — | ||
| Q3 25 | $0.22 | — | ||
| Q2 25 | $0.10 | — | ||
| Q1 25 | $0.37 | — | ||
| Q4 24 | $0.09 | — | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $-0.21 | — | ||
| Q1 24 | $-0.12 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $24.1M | — |
| 总债务越低越好 | $103.1M | — |
| 股东权益账面价值 | $-58.5M | — |
| 总资产 | $107.6M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BTMD
IMCC
| Q4 25 | $24.1M | — | ||
| Q3 25 | $28.0M | — | ||
| Q2 25 | $19.6M | — | ||
| Q1 25 | $41.7M | — | ||
| Q4 24 | $39.3M | $630.0K | ||
| Q3 24 | $38.2M | — | ||
| Q2 24 | $26.4M | $511.0K | ||
| Q1 24 | $78.8M | — |
总债务
BTMD
IMCC
| Q4 25 | $103.1M | — | ||
| Q3 25 | $104.7M | — | ||
| Q2 25 | $106.3M | — | ||
| Q1 25 | $107.8M | — | ||
| Q4 24 | $109.4M | — | ||
| Q3 24 | $110.9M | — | ||
| Q2 24 | $112.5M | — | ||
| Q1 24 | $114.1M | — |
股东权益
BTMD
IMCC
| Q4 25 | $-58.5M | — | ||
| Q3 25 | $-72.8M | — | ||
| Q2 25 | $-85.1M | — | ||
| Q1 25 | $-90.0M | — | ||
| Q4 24 | $-105.9M | $2.3M | ||
| Q3 24 | $-130.3M | — | ||
| Q2 24 | $-143.2M | $4.0M | ||
| Q1 24 | $-36.0M | — |
总资产
BTMD
IMCC
| Q4 25 | $107.6M | — | ||
| Q3 25 | $111.3M | — | ||
| Q2 25 | $104.8M | — | ||
| Q1 25 | $123.4M | — | ||
| Q4 24 | $122.4M | $28.6M | ||
| Q3 24 | $101.3M | — | ||
| Q2 24 | $92.9M | $29.4M | ||
| Q1 24 | $160.1M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $7.6M | $2.3K |
| 自由现金流经营现金流 - 资本支出 | $6.5M | $2.2K |
| 自由现金流率自由现金流/营收 | 14.0% | 21.6% |
| 资本支出强度资本支出/营收 | 2.3% | 0.9% |
| 现金转化率经营现金流/净利润 | 3.87× | — |
| 过去12个月自由现金流最近4个季度 | $30.2M | — |
8季度趋势,按日历期对齐
经营现金流
BTMD
IMCC
| Q4 25 | $7.6M | — | ||
| Q3 25 | $14.1M | $2.3K | ||
| Q2 25 | $7.1M | — | ||
| Q1 25 | $6.5M | — | ||
| Q4 24 | $12.4M | $-786.2K | ||
| Q3 24 | $15.6M | — | ||
| Q2 24 | $9.9M | — | ||
| Q1 24 | $7.4M | $-4.4K |
自由现金流
BTMD
IMCC
| Q4 25 | $6.5M | — | ||
| Q3 25 | $13.6M | $2.2K | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $4.8M | — | ||
| Q4 24 | $10.7M | — | ||
| Q3 24 | $14.0M | — | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $6.7M | $-4.7K |
自由现金流率
BTMD
IMCC
| Q4 25 | 14.0% | — | ||
| Q3 25 | 28.3% | 21.6% | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 27.3% | — | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | 14.2% | -51.7% |
资本支出强度
BTMD
IMCC
| Q4 25 | 2.3% | — | ||
| Q3 25 | 1.0% | 0.9% | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 1.5% | 3.3% |
现金转化率
BTMD
IMCC
| Q4 25 | 3.87× | — | ||
| Q3 25 | 1.72× | — | ||
| Q2 25 | 2.22× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 3.34× | — | ||
| Q3 24 | 1.45× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BTMD
| Product Revenue | $45.3M | 98% |
| Disposable Trocars Product Revenue | $1.2M | 3% |
IMCC
暂无分部数据